REPORT ID 4401

Global Cancer Gene Therapy Sales Market Report 2019

Publish Date
2019
Pages
122
Format
Electronic (PDF)

In this report, the global Cancer Gene Therapy market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Cancer Gene Therapy for these regions, from   2019 to 2025 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Cancer Gene Therapy market competition by top manufacturers/players, with Cancer Gene Therapy sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Adaptimmune
    GlaxoSmithKline
    Bluebird bio
    Merck
    Celgene
    Shanghai Sunway Biotech
    BioCancell
    Shenzhen SiBiono GeneTech
    SynerGene Therapeutics
    OncoGenex Pharmaceuticals
    Genelux Corporation
    Cell Genesys
    Advantagene
    GenVec
    BioCancell
    Celgene
    Epeius Biotechnologies
    Introgen Therapeutics
    Ziopharm Oncology
    Shenzhen SiBiono GeneTech
    Altor Bioscience
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Gene Induced Immunotherapy
    Oncolytic Virotherapy
    Gene Transfer
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Diagnostics Centers
    Research Institutes

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Cancer Gene Therapy Sales Market  Report 2019
1 Cancer Gene Therapy Market Overview
    1.1 Product Overview and Scope of Cancer Gene Therapy
    1.2 Classification of Cancer Gene Therapy by Product Category
        1.2.1 Global Cancer Gene Therapy Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 Global Cancer Gene Therapy Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Gene Induced Immunotherapy
        1.2.4 Oncolytic Virotherapy
        1.2.5 Gene Transfer
    1.3 Global Cancer Gene Therapy Market by Application/End Users
        1.3.1 Global Cancer Gene Therapy Sales (Volume) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Hospitals
        1.3.3 Diagnostics Centers
        1.3.4 Research Institutes
    1.4 Global Cancer Gene Therapy Market by Region
        1.4.1 Global Cancer Gene Therapy Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 United States Cancer Gene Therapy Status and Prospect ( 2014-2024)
        1.4.3 China Cancer Gene Therapy Status and Prospect ( 2014-2024)
        1.4.4 Europe Cancer Gene Therapy Status and Prospect ( 2014-2024)
        1.4.5 Japan Cancer Gene Therapy Status and Prospect ( 2014-2024)
        1.4.6 Southeast Asia Cancer Gene Therapy Status and Prospect ( 2014-2024)
        1.4.7 India Cancer Gene Therapy Status and Prospect ( 2014-2024)
    1.5 Global Market Size (Value and Volume) of Cancer Gene Therapy ( 2014-2024)
        1.5.1 Global Cancer Gene Therapy Sales and Growth Rate ( 2014-2024)
        1.5.2 Global Cancer Gene Therapy Revenue and Growth Rate ( 2014-2024)

2 Global Cancer Gene Therapy Competition by Players/Suppliers, Type and Application
     2.1 Global Cancer Gene Therapy Market Competition by Players/Suppliers
        2.1.1 Global Cancer Gene Therapy Sales and Market Share of Key Players/Suppliers ( 2014-2019)
        2.1.2 Global Cancer Gene Therapy Revenue and Share by Players/Suppliers ( 2014-2019)
    2.2 Global Cancer Gene Therapy (Volume and Value) by Type
        2.2.1 Global Cancer Gene Therapy Sales and Market Share by Type ( 2014-2019)
        2.2.2 Global Cancer Gene Therapy Revenue and Market Share by Type ( 2014-2019)
    2.3 Global Cancer Gene Therapy (Volume and Value) by Region
        2.3.1 Global Cancer Gene Therapy Sales and Market Share by Region ( 2014-2019)
        2.3.2 Global Cancer Gene Therapy Revenue and Market Share by Region ( 2014-2019)
    2.4 Global Cancer Gene Therapy (Volume) by Application

3 United States Cancer Gene Therapy (Volume, Value and Sales Price)
    3.1 United States Cancer Gene Therapy Sales and Value ( 2014-2019)
        3.1.1 United States Cancer Gene Therapy Sales and Growth Rate ( 2014-2019)
        3.1.2 United States Cancer Gene Therapy Revenue and Growth Rate ( 2014-2019)
        3.1.3 United States Cancer Gene Therapy Sales Price Trend ( 2014-2019)
    3.2 United States Cancer Gene Therapy Sales Volume and Market Share by Players
    3.3 United States Cancer Gene Therapy Sales Volume and Market Share by Type
    3.4 United States Cancer Gene Therapy Sales Volume and Market Share by Application

4 China Cancer Gene Therapy (Volume, Value and Sales Price)
    4.1 China Cancer Gene Therapy Sales and Value ( 2014-2019)
        4.1.1 China Cancer Gene Therapy Sales and Growth Rate ( 2014-2019)
        4.1.2 China Cancer Gene Therapy Revenue and Growth Rate ( 2014-2019)
        4.1.3 China Cancer Gene Therapy Sales Price Trend ( 2014-2019)
    4.2 China Cancer Gene Therapy Sales Volume and Market Share by Players
    4.3 China Cancer Gene Therapy Sales Volume and Market Share by Type
    4.4 China Cancer Gene Therapy Sales Volume and Market Share by Application

5 Europe Cancer Gene Therapy (Volume, Value and Sales Price)
    5.1 Europe Cancer Gene Therapy Sales and Value ( 2014-2019)
        5.1.1 Europe Cancer Gene Therapy Sales and Growth Rate ( 2014-2019)
        5.1.2 Europe Cancer Gene Therapy Revenue and Growth Rate ( 2014-2019)
        5.1.3 Europe Cancer Gene Therapy Sales Price Trend ( 2014-2019)
    5.2 Europe Cancer Gene Therapy Sales Volume and Market Share by Players
    5.3 Europe Cancer Gene Therapy Sales Volume and Market Share by Type
    5.4 Europe Cancer Gene Therapy Sales Volume and Market Share by Application

6 Japan Cancer Gene Therapy (Volume, Value and Sales Price)
    6.1 Japan Cancer Gene Therapy Sales and Value ( 2014-2019)
        6.1.1 Japan Cancer Gene Therapy Sales and Growth Rate ( 2014-2019)
        6.1.2 Japan Cancer Gene Therapy Revenue and Growth Rate ( 2014-2019)
        6.1.3 Japan Cancer Gene Therapy Sales Price Trend ( 2014-2019)
    6.2 Japan Cancer Gene Therapy Sales Volume and Market Share by Players
    6.3 Japan Cancer Gene Therapy Sales Volume and Market Share by Type
    6.4 Japan Cancer Gene Therapy Sales Volume and Market Share by Application

7 Southeast Asia Cancer Gene Therapy (Volume, Value and Sales Price)
    7.1 Southeast Asia Cancer Gene Therapy Sales and Value ( 2014-2019)
        7.1.1 Southeast Asia Cancer Gene Therapy Sales and Growth Rate ( 2014-2019)
        7.1.2 Southeast Asia Cancer Gene Therapy Revenue and Growth Rate ( 2014-2019)
        7.1.3 Southeast Asia Cancer Gene Therapy Sales Price Trend ( 2014-2019)
    7.2 Southeast Asia Cancer Gene Therapy Sales Volume and Market Share by Players
    7.3 Southeast Asia Cancer Gene Therapy Sales Volume and Market Share by Type
    7.4 Southeast Asia Cancer Gene Therapy Sales Volume and Market Share by Application

8 India Cancer Gene Therapy (Volume, Value and Sales Price)
    8.1 India Cancer Gene Therapy Sales and Value ( 2014-2019)
        8.1.1 India Cancer Gene Therapy Sales and Growth Rate ( 2014-2019)
        8.1.2 India Cancer Gene Therapy Revenue and Growth Rate ( 2014-2019)
        8.1.3 India Cancer Gene Therapy Sales Price Trend ( 2014-2019)
    8.2 India Cancer Gene Therapy Sales Volume and Market Share by Players
    8.3 India Cancer Gene Therapy Sales Volume and Market Share by Type
    8.4 India Cancer Gene Therapy Sales Volume and Market Share by Application

9 Global Cancer Gene Therapy Players/Suppliers Profiles and Sales Data
    9.1 Adaptimmune
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Cancer Gene Therapy Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Adaptimmune Cancer Gene Therapy Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.1.4 Main Business/Business Overview
    9.2 GlaxoSmithKline
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Cancer Gene Therapy Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 GlaxoSmithKline Cancer Gene Therapy Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.2.4 Main Business/Business Overview
    9.3 Bluebird bio
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Cancer Gene Therapy Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Bluebird bio Cancer Gene Therapy Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.3.4 Main Business/Business Overview
    9.4 Merck
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Cancer Gene Therapy Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Merck Cancer Gene Therapy Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.4.4 Main Business/Business Overview
    9.5 Celgene
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Cancer Gene Therapy Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Celgene Cancer Gene Therapy Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.5.4 Main Business/Business Overview
    9.6 Shanghai Sunway Biotech
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Cancer Gene Therapy Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Shanghai Sunway Biotech Cancer Gene Therapy Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.6.4 Main Business/Business Overview
    9.7 BioCancell
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Cancer Gene Therapy Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 BioCancell Cancer Gene Therapy Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.7.4 Main Business/Business Overview
    9.8 Shenzhen SiBiono GeneTech
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Cancer Gene Therapy Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.8.4 Main Business/Business Overview
    9.9 SynerGene Therapeutics
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Cancer Gene Therapy Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 SynerGene Therapeutics Cancer Gene Therapy Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.9.4 Main Business/Business Overview
    9.10 OncoGenex Pharmaceuticals
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Cancer Gene Therapy Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.10.4 Main Business/Business Overview
    9.11 Genelux Corporation
    9.12 Cell Genesys
    9.13 Advantagene
    9.14 GenVec
    9.15 BioCancell
    9.16 Celgene
    9.17 Epeius Biotechnologies
    9.18 Introgen Therapeutics
    9.19 Ziopharm Oncology
    9.20 Shenzhen SiBiono GeneTech
    9.21 Altor Bioscience

10 Cancer Gene Therapy Maufacturing Cost Analysis
    10.1 Cancer Gene Therapy Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Cancer Gene Therapy
    10.3 Manufacturing Process Analysis of Cancer Gene Therapy

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Cancer Gene Therapy Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Cancer Gene Therapy Major Manufacturers  in 2018
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Cancer Gene Therapy Market Forecast ( 2019-2025)
    14.1 Global Cancer Gene Therapy Sales Volume, Revenue and Price Forecast ( 2019-2025)
       14.1.1 Global Cancer Gene Therapy Sales Volume and Growth Rate Forecast ( 2019-2025)
       14.1.2 Global Cancer Gene Therapy Revenue and Growth Rate Forecast ( 2019-2025)
       14.1.3 Global Cancer Gene Therapy Price and Trend Forecast ( 2019-2025)
    14.2 Global Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast by Region ( 2019-2025)
       14.2.1 Global Cancer Gene Therapy Sales Volume and Growth Rate Forecast by Regions ( 2019-2025)
       14.2.2 Global Cancer Gene Therapy Revenue and Growth Rate Forecast by Regions ( 2019-2025)
       14.2.3 United States Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.4 China Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.5 Europe Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.6 Japan Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.7 Southeast Asia Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.8 India Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
    14.3 Global Cancer Gene Therapy Sales Volume, Revenue and Price Forecast by Type ( 2019-2025)
       14.3.1 Global Cancer Gene Therapy Sales Forecast by Type ( 2019-2025)
       14.3.2 Global Cancer Gene Therapy Revenue Forecast by Type ( 2019-2025)
       14.3.3 Global Cancer Gene Therapy Price Forecast by Type ( 2019-2025)
    14.4 Global Cancer Gene Therapy Sales Volume Forecast by Application ( 2019-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer